Federal award
WAMPOLE LABORATORIES, LLC
W81K0007P0596
Contract
Obligated and Ceiling
- Obligated (net)
- $133,822.36
- Ceiling (potential value, not spending)
- —
- Current value
- —
- Gross positive obligations
- $134,259.38
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- WAMPOLE LABORATORIES, LLC · NA46NA4UDFW9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ALERE INC. · DR3DJB88EBS7
- Awarding agency
- Department of War · sub-agency 2100 · office W91YU0
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0007P0596
- Award type code
- B
- Actions
- 11 · Oct 4, 2007 to May 20, 2010
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 20, 2010 | FY2010 | P00012 | D | $5,188.00 | — |
| Oct 6, 2009 | FY2010 | P00011 | C | $43,001.18 | — |
| Jul 2, 2009 | FY2009 | P00010 | D | −$437.02 | — |
| Jun 22, 2009 | FY2009 | P00009 | M | $0.00 | — |
| May 4, 2009 | FY2009 | P00008 | G | $0.00 | — |
| Nov 12, 2008 | FY2009 | P00007 | D | $5,994.60 | — |
| Oct 9, 2008 | FY2009 | P00006 | C | $37,443.60 | — |
| Sep 19, 2008 | FY2008 | P00005 | D | $0.00 | — |
| Jul 24, 2008 | FY2008 | P00004 | D | $0.00 | — |
| Jul 14, 2008 | FY2008 | P00003 | G | $5,188.00 | — |
| Oct 4, 2007 | FY2008 | P00002 | C | $37,444.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.